Detalles de la búsqueda
1.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 689-699, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
2.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755516
3.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 700-705, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696053
4.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
5.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
6.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
7.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
8.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494578
9.
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865026
10.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(6): 681-688, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
11.
Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.
Int J Clin Oncol
; 26(5): 971-979, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33768450
12.
Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.
Gynecol Oncol
; 157(1): 115-120, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31983515
13.
Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Carcinogenesis
; 40(5): 611-623, 2019 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30850842
14.
Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial.
Gynecol Oncol
; 155(3): 413-419, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601493
15.
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.
Cancer Sci
; 109(2): 471-482, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247567
16.
UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan.
Jpn J Clin Oncol
; 47(2): 170-174, 2017 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28173214
17.
Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.
Jpn J Clin Oncol
; 47(5): 401-406, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334914
18.
A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer.
Int J Gynecol Cancer
; 27(7): 1517-1524, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28562470
19.
Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.
J Obstet Gynaecol Res
; 43(4): 744-748, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370831
20.
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.
Reprod Biol Endocrinol
; 14: 2, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26769300